These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34883448)

  • 1. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying FLNC exon skipping variant.
    Ader F; Duboscq-Bidot L; Marteau S; Hamlin M; Richard P; Fontaine V; Villard E
    Stem Cell Res; 2022 Jan; 58():102616. PubMed ID: 34883448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
    Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
    Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
    Qin Z; Sun L; Sun X; Su H; Gao X
    Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
    Kojic A; Kim H; Guevara JV; Ravada S; Sallam K; Wu JC
    Stem Cell Res; 2022 Oct; 64():102928. PubMed ID: 36194907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy.
    Argenziano MA; Burgos Angulo M; Najari Beidokhti M; Yang J; Bertalovitz AC; McDonald TV
    Stem Cell Res; 2021 May; 53():102394. PubMed ID: 34088019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
    Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
    Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias.
    Ohiri JC; Dellefave-Castillo L; Tomar G; Wilsbacher L; Choudhury L; Barefield DY; Fullenkamp D; Gacita AM; Monroe TO; Pesce L; Blancard M; Vaught L; George AL; Demonbreun AR; Puckelwartz MJ; McNally EM
    J Am Heart Assoc; 2024 May; 13(10):e030467. PubMed ID: 38761081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying BAG3 V468M mutation in its BAG domain.
    Duboscq-Bidot L; Hoareau B; Ader F; Fontaine V; Villard E
    Stem Cell Res; 2024 Feb; 74():103294. PubMed ID: 38183888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filamin C Deficiency Impairs Sarcomere Stability and Activates Focal Adhesion Kinase through PDGFRA Signaling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Gao S; He L; Lam CK; Taylor MRG; Mestroni L; Lombardi R; Chen SN
    Cells; 2024 Feb; 13(3):. PubMed ID: 38334670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of CRISPR/Cas9 edited human induced pluripotent stem cell line carrying the heterozygous p.H695VfsX5 frameshift mutation in the exon 10 of the PKP2 gene.
    Pierre B; Laëtitia DB; Camille B; Claire P; Elise B; Estelle G; Vincent F; Eric V
    Stem Cell Res; 2024 Apr; 76():103341. PubMed ID: 38382214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Biomechanics and Pharmacological Rescue of Human Cardiomyocytes with Filamin C Truncations.
    Lazzarino M; Zanetti M; Chen SN; Gao S; Peña B; Lam CK; Wu JC; Taylor MRG; Mestroni L; Sbaizero O
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel splicing variant in FLNC gene responsible for a highly penetrant familial dilated cardiomyopathy in an extended Iranian family.
    Nozari A; Aghaei-Moghadam E; Zeinaloo A; Mollazadeh R; Majnoon MT; Alavi A; Ghasemi Firouzabadi S; Mohammadzadeh A; Banihashemi S; Nikzaban M; Najmabadi H; Behjati F
    Gene; 2018 Jun; 659():160-167. PubMed ID: 29551499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
    Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
    Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPE.
    Iwagawa T; Masumoto H; Tabuchi H; Tani K; Conklin BR; Watanabe S
    J Gene Med; 2023 Feb; 25(2):e3464. PubMed ID: 36413603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-negative blind deconvolution for signal processing in a CRISPR-edited iPSC-cardiomyocyte model of dilated cardiomyopathy.
    Xu H; Wali R; Cheruiyot C; Bodenschatz J; Hasenfuss G; Janshoff A; Habeck M; Ebert A
    FEBS Lett; 2021 Oct; 595(20):2544-2557. PubMed ID: 34482543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A).
    Djemai M; Jauvin D; Poulin H; Chapotte-Baldacci CA; Chahine M
    Stem Cell Res; 2024 Mar; 75():103308. PubMed ID: 38232626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system.
    Kang JY; Mun D; Chun Y; Park DS; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Oct; 64():102901. PubMed ID: 36037555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures.
    Begay RL; Graw SL; Sinagra G; Asimaki A; Rowland TJ; Slavov DB; Gowan K; Jones KL; Brun F; Merlo M; Miani D; Sweet M; Devaraj K; Wartchow EP; Gigli M; Puggia I; Salcedo EE; Garrity DM; Ambardekar AV; Buttrick P; Reece TB; Bristow MR; Saffitz JE; Mestroni L; Taylor MRG
    JACC Clin Electrophysiol; 2018 Apr; 4(4):504-514. PubMed ID: 30067491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control.
    Fontaine V; Duboscq-Bidot L; Jouve C; Hamlin M; Curjol A; Briand V; Janiak P; Hulot JS; Pruniaux-Harnist MP; Charron P; Villard E
    Stem Cell Res; 2021 Apr; 52():102245. PubMed ID: 33610018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.